
Sign up to save your podcasts
Or
In part 2 Prof. Nicolas Mottet discusses which are the most important changes in the new EAU Guidelines for Prostate Cancer treatment related to genetic testing, M1 disease and Castration-resistant prostate cancer (CRPC).
Listen also to part 1 about perineal biopsy, staging PSMA, adjuvant Radio Therapy.
3.7
33 ratings
In part 2 Prof. Nicolas Mottet discusses which are the most important changes in the new EAU Guidelines for Prostate Cancer treatment related to genetic testing, M1 disease and Castration-resistant prostate cancer (CRPC).
Listen also to part 1 about perineal biopsy, staging PSMA, adjuvant Radio Therapy.
7,728 Listeners
1,773 Listeners
318 Listeners
1,305 Listeners
486 Listeners
39 Listeners
2,415 Listeners
133 Listeners
56 Listeners
2 Listeners
0 Listeners
55 Listeners
0 Listeners
3,197 Listeners
0 Listeners